Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:36 PM
Study NCT ID:
NCT00763451
Status:
COMPLETED
Last Update Posted:
2016-12-14
First Post:
2008-09-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-30
First Submit QC Date:
None
Study First Post Date:
2008-10-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-18
Results First Submit QC Date:
None
Results First Post Date:
2016-12-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-02-23
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-10-21
Last Update Post Date:
2016-12-14
Last Update Post Date Type:
ESTIMATED